These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10027514)

  • 41. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M; Jacobs MP; Suy E; Minner B; Raus J
    Neuropsychobiology; 1989; 21(4):192-6. PubMed ID: 2561010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The hormonal response to a d-fenfluramine challenge in trained and sedentary men.
    Strachan AT; Maughan RJ
    Med Sci Sports Exerc; 1999 Apr; 31(4):547-53. PubMed ID: 10211850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum prolactin as a correlate of clinical response to haloperidol.
    Van Putten T; Marder SR; Mintz J
    J Clin Psychopharmacol; 1991 Dec; 11(6):357-61. PubMed ID: 1770154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prolactinemia and predictability of therapeutic response of schizophrenic patients in acute decompensation].
    Vanelle JM; Amorim P; Piketti ML; Bourdel MC; Poirier-Littré MF
    Encephale; 1996 Oct; 22 Spec No 3():82-4. PubMed ID: 8954284
    [No Abstract]   [Full Text] [Related]  

  • 46. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
    Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
    Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abnormal prolactin response to haloperidol challenge in men with schizophrenia.
    Keks NA; Copolov DL; Singh BS
    Am J Psychiatry; 1987 Oct; 144(10):1335-7. PubMed ID: 3661768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests.
    Duval F; Mokrani MC; Monreal J; Bailey P; Valdebenito M; Crocq MA; Macher JP
    Psychoneuroendocrinology; 2003 Jul; 28(5):627-42. PubMed ID: 12727131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quetiapine is not associated with increase in prolactin secretion in contrast to haloperidol.
    Atmaca M; Kuloglu M; Tezcan E; Canatan H; Gecici O
    Arch Med Res; 2002; 33(6):562-5. PubMed ID: 12505103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
    Rao ML; Brown WA
    Psychopharmacology (Berl); 1987; 93(2):237-42. PubMed ID: 2892222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prolactin response to D-fenfluramine and suicidal behavior in depressed patients.
    Corrêa H; Duval F; Mokrani M; Bailey P; Trémeau F; Staner L; Diep TS; Hodé Y; Crocq MA; Macher JP
    Psychiatry Res; 2000 Apr; 93(3):189-99. PubMed ID: 10760377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fenfluramine challenge test in obsessive-compulsive disorder--first results.
    Pidrman V; Tůma I
    Acta Medica (Hradec Kralove); 1997; 40(4):99-102. PubMed ID: 9481883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):172-6. PubMed ID: 12242578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
    Lerer B; Gillon D; Lichtenberg P; Gorfine M; Gelfin Y; Shapira B
    Int Psychogeriatr; 1996; 8(1):83-102. PubMed ID: 8805090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inter-relationships of intermediate phenotypes for serotonin function, impulsivity, and a 5-HT2A candidate allele: His452Tyr.
    Reist C; Mazzanti C; Vu R; Fujimoto K; Goldman D
    Mol Psychiatry; 2004 Sep; 9(9):871-8. PubMed ID: 15037867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dosing the antipsychotic medication olanzapine.
    Nemeroff CB
    J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.
    Mulder RT; Porter RJ; Joyce PR
    J Psychopharmacol; 2003 Mar; 17(1):97-102. PubMed ID: 12680745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The neuroendocrine response to d-fenfluramine in women with premenstrual depression.
    Bancroft J; Cook A
    J Affect Disord; 1995 Dec; 36(1-2):57-64. PubMed ID: 8988266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test.
    Rajewska J; Rybakowski JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):705-9. PubMed ID: 12787860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolactin and cortisol responses to fenfluramine in Parkinson's disease.
    Kostić VS; Lecić D; Doder M; Marinković J; Filipović S
    Biol Psychiatry; 1996 Oct; 40(8):769-75. PubMed ID: 8894070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.